0001127602-23-008787.txt : 20230303 0001127602-23-008787.hdr.sgml : 20230303 20230303170459 ACCESSION NUMBER: 0001127602-23-008787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Munsch Frederick CENTRAL INDEX KEY: 0001864367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41380 FILM NUMBER: 23705501 MAIL ADDRESS: STREET 1: C/O BLCO STREET 2: 400 SOMERSET CORPORATE BLVD. CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch & Lomb Corp CENTRAL INDEX KEY: 0001860742 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 BUSINESS PHONE: 908-541-5456 MAIL ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-03-01 0001860742 Bausch & Lomb Corp BLCO 0001864367 Munsch Frederick C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 ONTARIO, CANADA 1 SVP, Controller and CAO Common Shares, No Par Value 2023-03-01 4 A 0 7529 0 A 41251 D Non-Qualified Stock Options (right to purchase) 17.96 2023-03-01 4 A 0 24103 0 A Common Shares, No Par Value 24103 24103 D Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Reflects the grant of stock options to purchase Common Shares under the Plan. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. The stock options will expire on the tenth anniversary of the grant date. /s/ Debra E. Levin, attorney-in-fact 2023-03-03